We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Albion Technology & General Vct Plc | LSE:AATG | London | Ordinary Share | GB0005581672 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 69.00 | 67.50 | 70.50 | 69.00 | 69.00 | 69.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | -2.85M | -6.3M | -0.0354 | -19.49 | 122.68M |
TIDMAATG ALBION TECHNOLOGY & GENERAL VCT PLC Issue of Equity and Total Voting Rights LEI Code 213800TKJUY376H3KN16 The first and final allotment for the 2021/2022 tax year of new ordinary shares of nominal value 1 penny per share ("New Ordinary Shares") in Albion Technology & General VCT PLC (the "Company") under the Albion VCTs Prospectus Top Up Offers 2020/21 (the "Offers"), (which was launched on 5 January 2021) took place on 9 April 2021. Pursuant to the prospectus setting out details of the Offers ("Prospectus"), the Company offered an early bird discount of 1% on issue costs to existing shareholders in the Companies and 0.5% on issue costs to new subscribers. These early bird discounts were available to investors who subscribed for New Ordinary Shares for the first GBP10 million received by 2 p.m. on 26 February 2021 across the five VCTs participating in the Offers. The Company has received valid applications under the Offers for the 2021/2022 tax year for 175,959 New Ordinary Shares which will be allotted at an issue price of 70.5 pence per share from existing shareholders in the Companies and 16,384 New Ordinary Shares allotted at an issue price of 70.8 pence per share for new subscribers, both of which qualified for the early bird discount. A further 497,978 New Ordinary Shares will be allotted at an issue price of 71.2 pence per share (which did not qualify for the early bird discount). The total net proceeds receivable by the Company for these allotments is approximately GBP0.5 million, bringing net total raised by the Company under the Prospectus to GBP15.1 million. Application has been made to the Financial Conduct Authority for 690,321 New Ordinary Shares to be admitted to the Official List and to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on the London Stock Exchange's market for listed securities. The New Ordinary Shares rank pari passu with the existing shares in issue. It is expected that admission to the Official List will become effective and that dealings in the New Ordinary Shares will commence within three Business Days following allotment. The Offers which constitute separate offers have been fully subscribed and all have been closed to further applications. The total amount raised across the Albion VCTs under the Offers is GBP58.5 million (of which GBP2.3 million relates to this tax year 2021/2022). Following this allotment and in conformity with the provisions of DTR 5.6, the Company makes the following notifications in connection with its issued share capital: The Company's capital as at 9 April 2021 consists of 152,522,591 ordinary shares with a nominal value of 1 penny each. The Company holds 18,196,470 ordinary shares in Treasury. Therefore, the total number of voting rights in the Company is 134,326,121 which may be used by shareholders and other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. For further information, please contact: Albion Capital Group LLP Company Secretary 020 7601 1850 9 April 2021
(END) Dow Jones Newswires
April 09, 2021 11:47 ET (15:47 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Albion Technology & Gene... Chart |
1 Month Albion Technology & Gene... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions